A Japanese drug manufacturer has ended its 340B contract pharmacy restrictions in Maryland and Mississippi in conjunction with new contract [...] …
Year: 2024
SPONSORED CONTENT
As the 340B program continues to grow in complexity, given the drug manufacturer restrictions, it is more important than ever for covered entities to have a firm grasp and understanding of the fees charged by their Third Party Adminisrators (TPAs) for their contract pharmacies. Whether it is
…
The West Virginia attorney general and multiple hospital groups recently urged a federal district judge to deny Novartis’ motion to [...] …
Two major drug manufacturers are suing Minnesota to block a new 340B contract pharmacy access law, which took effect this [...] …
A group of Texas hospitals urged a federal court last week to grant their request for a summary judgement—or at [...] …
![](/wp-content/uploads/2024/04/spotlight.png)
340B INDUSTRY LEADER SPOTLIGHT
Kimberly Lott, Vice President of Patient Care Coordination, AuthorityRx
![](https://340breport.com/wp-content/uploads/2024/06/Kim-Lott_512x512-2.png)
I grew up in a small rural town called Meade, Kansas. For the last 20 years, I have called the Kansas City area home.
Read More »
The 340B program faces unprecedented challenges despite a series of states enacting 340B contract pharmacy access laws, the leader of [...] …
Two major drug manufacturers this week sued Kansas in an effort to block the state’s new contract pharmacy access law, [...] …
News Alert
Federal Judge Denies Drugmakers’ Bids to Block Mississippi’s New 340B Contract Pharmacy Access Law
A federal district judge has rejected two drug industry attempts to block Mississippi’s new state law prohibiting drugmaker 340B contract [...] …
Missouri Gov. Mike Parson (R) has less than two weeks to decide the fate of a 340B contract pharmacy access [...] …